Company Directory / medical practice

PrivateFor profitmedical practiceBurlingame, United States
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.
Size
11-50 people: larger than 33% of companies with a size listed
Age
7 years old.
Reach
Website ranked #3,675,413 in the world for traffic, about 3k visits a month.
Artificial Intelligence (AI)BiotechnologyInformation Technology
Funding, as listed
$256M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Genesis Therapeutics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Genesis Therapeutics may be growing as it has recently joined a list of AI-powered drug discovery startups receiving venture funding, indicating an influx of capital which is a positive sign of investor confidence and potential for expansion. The company successfully closed a significant $200 million Series B financing round, co-led by a prominent venture firm, which provides substantial financial resources to support its operations and research initiatives. This level of funding is typically indicative of a company scaling up its business and investing in further development.
Summaries written by the source dataset, not by us, and not checked.
medical practice in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.